Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs16754
rs16754
WT1
0.010 GeneticVariation BEFREE Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia. 26224397

2015

dbSNP: rs56149945
rs56149945
0.010 GeneticVariation BEFREE We investigated whether an altered individual glucocorticoid sensitivity due to particular glucocorticoid receptor single-nucleotide polymorphisms (SNPs) (N363S, ER22/23EK, and Bcl-1) influences the susceptibility to steroid-related toxicities, prognostic factors, and survival rates in children with acute lymphoblastic leukemia. 27050122

2016

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE We investigated preliminarily whether methylenetetrahydrofolate reductase (MTHFR) 677C/T or reduced folate carrier 1 (RFC1) 80G/A polymorphisms were associated with toxicities during maintenance chemotherapy with mercaptopurine (6MP) and methotrexate (MTX) in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. 18458567

2008

dbSNP: rs368087026
rs368087026
0.010 GeneticVariation BEFREE We investigated preliminarily whether methylenetetrahydrofolate reductase (MTHFR) 677C/T or reduced folate carrier 1 (RFC1) 80G/A polymorphisms were associated with toxicities during maintenance chemotherapy with mercaptopurine (6MP) and methotrexate (MTX) in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. 18458567

2008

dbSNP: rs775144154
rs775144154
0.010 GeneticVariation BEFREE We investigated preliminarily whether methylenetetrahydrofolate reductase (MTHFR) 677C/T or reduced folate carrier 1 (RFC1) 80G/A polymorphisms were associated with toxicities during maintenance chemotherapy with mercaptopurine (6MP) and methotrexate (MTX) in children with acute lymphoblastic leukemia or lymphoblastic lymphoma. 18458567

2008

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE We investigated a possible association of MTHFR polymorphisms (677C>T and 1298A>C) and increased risk for acute lymphoblastic leukemia in 78 affected children. 20445408

2010

dbSNP: rs397507444
rs397507444
0.070 GeneticVariation BEFREE We investigated a possible association of MTHFR polymorphisms (677C>T and 1298A>C) and increased risk for acute lymphoblastic leukemia in 78 affected children. 20445408

2010

dbSNP: rs3731217
rs3731217
0.010 GeneticVariation BEFREE Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage. 20453839

2010

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. 29911750

2018

dbSNP: rs6479778
rs6479778
0.010 GeneticVariation BEFREE Under the dominant model, SNPs rs7073837, rs10821936, rs7896246, and rs6479778 in males only showed striking association with acute lymphoblastic leukemia. 28381164

2017

dbSNP: rs7896246
rs7896246
0.710 GeneticVariation BEFREE Under the dominant model, SNPs rs7073837, rs10821936, rs7896246, and rs6479778 in males only showed striking association with acute lymphoblastic leukemia. 28381164

2017

dbSNP: rs1966862
rs1966862
0.010 GeneticVariation BEFREE This study suggested rs1966862 (ARHGAP24) and the other SNPs to be predictive factors for drug-induced hepatotoxicity during the maintenance phase in pediatric patients with ALL or LBL. 20670164

2010

dbSNP: rs1057519753
rs1057519753
0.010 GeneticVariation BEFREE This mutation was identical to the JAK1 V658F mutation previously found in human APL and acute lymphoblastic leukemia samples. 21436584

2011

dbSNP: rs121913448
rs121913448
0.010 GeneticVariation BEFREE The Ph (+) ALL patient had a Glu255Lys mutation in exon 5 and a Thr315Ile mutation in exon 7. 18603297

2008

dbSNP: rs387906517
rs387906517
0.010 GeneticVariation BEFREE The Ph (+) ALL patient had a Glu255Lys mutation in exon 5 and a Thr315Ile mutation in exon 7. 18603297

2008

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: an updated meta-analysis based on 37 case-control studies. 24377532

2013

dbSNP: rs397507444
rs397507444
0.070 GeneticVariation BEFREE The effect of RFC G80A polymorphism in Cretan children with acute lymphoblastic leukemia and its interaction with MTHFR C677T and A1298C polymorphisms. 24237708

2014

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The effect of RFC G80A polymorphism in Cretan children with acute lymphoblastic leukemia and its interaction with MTHFR C677T and A1298C polymorphisms. 24237708

2014

dbSNP: rs121913459
rs121913459
0.020 GeneticVariation BEFREE The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients. 22587422

2012

dbSNP: rs1217691063
rs1217691063
0.100 GeneticVariation BEFREE The authors describe the case of a 12-year-old male with acute lymphoblastic leukemia and a homozygous methylenetetrahydrofolate reductase C677T mutation, who developed subacute methotrexate-induced toxicity and cerebral venous thrombosis after receiving intrathecal methotrexate. 20121554

2010

dbSNP: rs1801265
rs1801265
0.010 GeneticVariation BEFREE The authors conclude that patients carrying the c.85T>C C allele have an increased risk of developing acute lymphoblastic leukemia and have inferior outcome, and that DPYD c.85T>C can be used as a guide for individualized treatment and the decision to utilize 5-fluorouracil in acute lymphoblastic leukemia patients. 28618970

2017

dbSNP: rs3794845
rs3794845
MBP
0.010 GeneticVariation BEFREE Subgroup analysis showed that Ly96 rs78380171 and MBP rs3794845 were significantly associated with the risk of acute lymphoblastic leukemia (p(trend) < 0.001). 20438785

2010

dbSNP: rs78380171
rs78380171
0.010 GeneticVariation BEFREE Subgroup analysis showed that Ly96 rs78380171 and MBP rs3794845 were significantly associated with the risk of acute lymphoblastic leukemia (p(trend) < 0.001). 20438785

2010

dbSNP: rs1695
rs1695
0.010 GeneticVariation BEFREE Role of GSTM1 (Present/Null) and GSTP1 (Ile105Val) polymorphisms in susceptibility to acute lymphoblastic leukemia among the South Indian population. 19256768

2009

dbSNP: rs121913615
rs121913615
MPL
0.010 GeneticVariation BEFREE Retrospective molecular studies detected a MPL W515S homozygous mutation in both the initial and remission marrows for B-ALL, at 30-40% and 80% dosage effect, respectively. 25453399

2015